Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By

Top 5 search results for "Votrient" in Resources. To see all results and access other features, sign up for free.

... Carcinoma Metastasizing to the Cricoid Cartilage Presenting With Subglottic Stenosis: A Case Report and Literature Review — Ear, Nose & Throat Journal Unusual Head and Neck Presentation of Metastatic Renal Cell Carcinoma — Otolaryngology Case Reports Managing Side Effects — Kidney Cancer Canada Everolimus (Afinitor) — Cancer Research UK Pazopanib (Votrient ...
Can Kidney Cancer Spread to the Throat? When To Worry About a Sore Throat
... Carcinoma Metastasizing to the Cricoid Cartilage Presenting With Subglottic Stenosis: A Case Report and Literature Review — Ear, Nose & Throat Journal Unusual Head and Neck Presentation of Metastatic Renal Cell Carcinoma — Otolaryngology Case Reports Managing Side Effects — Kidney Cancer Canada Everolimus (Afinitor) — Cancer Research UK Pazopanib (Votrient ...
... Anup Ramani Kidney Cancer Symptoms — The University of Texas MD Anderson Cancer Center Diagnosis and Staging — Kidney Cancer Association Everolimus (Afinitor) — Cancer Research UK Lymphedema — National Cancer Institute Pazopanib (Votrient) — Cancer Research UK Cabozantinib — Memorial Sloan Kettering Cancer Center Lenvatinib (Oral Route) — Mayo Clinic ...
Kidney Cancer and Swelling: Causes and Remedies for Edema
... Anup Ramani Kidney Cancer Symptoms — The University of Texas MD Anderson Cancer Center Diagnosis and Staging — Kidney Cancer Association Everolimus (Afinitor) — Cancer Research UK Lymphedema — National Cancer Institute Pazopanib (Votrient) — Cancer Research UK Cabozantinib — Memorial Sloan Kettering Cancer Center Lenvatinib (Oral Route) — Mayo Clinic ...
... treat advanced kidney cancer, but they may be helpful as an adjuvant therapy to lower the risk of recurrence after surgery.Several different targeted therapy drugs can be used to treat kidney cancer, including: Axitinib (Inlyta) Belzutifan (Welireg) Bevacizumab (Avastin) Cabozantinib (Cabometyx) Everolimus (Afinitor) Lenvatinib (Lenvima) Pazopanib (Votrient ...
8 Kidney Cancer Treatments: Surgery, Immunotherapy, Targeted Therapy, and More
... treat advanced kidney cancer, but they may be helpful as an adjuvant therapy to lower the risk of recurrence after surgery.Several different targeted therapy drugs can be used to treat kidney cancer, including: Axitinib (Inlyta) Belzutifan (Welireg) Bevacizumab (Avastin) Cabozantinib (Cabometyx) Everolimus (Afinitor) Lenvatinib (Lenvima) Pazopanib (Votrient ...
... Most TKIs are FDA-approved to treat RCC.Examples of TKIs include: Axitinib (Inlyta) Cabozantinib (Cabometyx) Lenvatinib (Lenvima) Pazopanib (Votrient) Sorafenib (Nexavar) Sunitinib (Sutent) Tivozanib (Fotivda) Your doctor will choose a TKI depending on other treatments you’ve tried before. ...
Metastatic Kidney Cancer: Symptoms and Treatment Options
... Most TKIs are FDA-approved to treat RCC.Examples of TKIs include: Axitinib (Inlyta) Cabozantinib (Cabometyx) Lenvatinib (Lenvima) Pazopanib (Votrient) Sorafenib (Nexavar) Sunitinib (Sutent) Tivozanib (Fotivda) Your doctor will choose a TKI depending on other treatments you’ve tried before. ...
... Without a blood supply, tumors have a harder time getting the oxygen and nutrients they need to grow.Targeted therapies used for kidney cancer include: Axitinib Belzutifan (Welireg) Cabozantinib (Cabometyx) Lenvatinib (Lenvima) Pazopanib (Votrient) Sunitinib malate (Sutent) Tivozanib (Fotivda) These medicines are often part of combination treatments ...
6 Types of Immunotherapy for Kidney Cancer
... Without a blood supply, tumors have a harder time getting the oxygen and nutrients they need to grow.Targeted therapies used for kidney cancer include: Axitinib Belzutifan (Welireg) Cabozantinib (Cabometyx) Lenvatinib (Lenvima) Pazopanib (Votrient) Sunitinib malate (Sutent) Tivozanib (Fotivda) These medicines are often part of combination treatments ...